Elicio Therapeutics, Inc. Common Stock (ELTX) is a publicly traded Healthcare sector company. As of May 21, 2026, ELTX trades at $10.35 with a market cap of $182.65M and a P/E ratio of -3.85. ELTX moved +8.18% today. Year to date, ELTX is +26.84%; over the trailing twelve months it is +81.27%. Its 52-week range spans $4.05 to $14.93. Analyst consensus is strong buy with an average price target of $18.00. Rallies surfaces ELTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own ELTX include Citadel Advisors and Renaissance Technologies. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Elicio Therapeutics, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $10.35 |
| Market Cap | $182.65M |
| P/E Ratio | -3.85 |
| EPS | $-2.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.93 |
| 52-Week Low | $4.05 |
| Volume | 220 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-39.57M |
| Gross Margin | 0.00% |
4 analysts cover ELTX: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $18.00.